secwatch.observer — SEC 8-K summary
======================================

Issuer:     ABVC BIOPHARMA, INC. (ABVC)
CIK:        0001173313
Form:       8-K
Filed at:   2023-04-24T23:59:59+00:00
Accession:  0001213900-23-031964
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ABVC BioPharma shareholders re-elect 11 directors, ratify auditor, approve share issuance for Lind note conversion
--------------------------------------------------------------------------------

- All 11 director nominees re-elected; votes ranged from 18.79M to 18.86M for, with 0 against.
- Ratification of WWC P.C. as auditor for FY 2023: 19,388,899 for, 86,207 against, 5,010 abstain.
- Authorization to issue shares underlying convertible notes and warrants to Lind Global Fund II LP passed: 18,835,192 for, 115,688 against.
- Quorum of 19,480,116 shares (58.88% voting power) represented at meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1173313/000121390023031964/0001213900-23-031964-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1173313/000121390023031964/ea177375-8k_abvcbio.htm
  HTML page:      https://secwatch.observer/filing/0001213900-23-031964

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer